China Health Industries Holdings, Inc. (CHHE) Return on Sales (2017 - 2024)
China Health Industries Holdings (CHHE) has disclosed Return on Sales for 14 consecutive years, with 1640.83% as the latest value for Q1 2024.
- For the quarter ending Q1 2024, Return on Sales fell 162727.0% year-over-year to 1640.83%, compared with a TTM value of 14.2% through Mar 2024, down 2280.0%, and an annual FY2023 reading of 3.66%, up 132199.0% over the prior year.
- Return on Sales was 1640.83% for Q1 2024 at China Health Industries Holdings, up from 9686.02% in the prior quarter.
- Across five years, Return on Sales topped out at 35.68% in Q4 2022 and bottomed at 286762.0% in Q4 2021.
- Average Return on Sales over 5 years is 49323.84%, with a median of 10.28% recorded in 2023.
- The sharpest move saw Return on Sales crashed -28676226bps in 2021, then soared 28679768bps in 2022.
- Year by year, Return on Sales stood at 0.26% in 2020, then crashed by -108574420bps to 286762.0% in 2021, then soared by 100bps to 35.68% in 2022, then plummeted by -27247bps to 9686.02% in 2023, then surged by 83bps to 1640.83% in 2024.
- Business Quant data shows Return on Sales for CHHE at 1640.83% in Q1 2024, 9686.02% in Q4 2023, and 4.76% in Q3 2023.